- Home
- CHEB vs MGX Comparison
CHEB vs MGX Comparison
Compare CHEB & MGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEB
- MGX
- Stock Information
- Founded
- CHEB 2024
- MGX 2018
- Country
- CHEB Singapore
- MGX United States
- Employees
- CHEB N/A
- MGX N/A
- Industry
- CHEB
- MGX
- Sector
- CHEB
- MGX
- Exchange
- CHEB NYSE
- MGX NYSE
- Market Cap
- CHEB 119.4M
- MGX 150.1M
- IPO Year
- CHEB 2024
- MGX 2024
- Fundamental
- Price
- CHEB $10.11
- MGX $2.76
- Analyst Decision
- CHEB
- MGX Strong Buy
- Analyst Count
- CHEB 0
- MGX 7
- Target Price
- CHEB N/A
- MGX $16.67
- AVG Volume (30 Days)
- CHEB 30.9K
- MGX 1.3M
- Earning Date
- CHEB 01-01-0001
- MGX 02-12-2025
- Dividend Yield
- CHEB N/A
- MGX N/A
- EPS Growth
- CHEB N/A
- MGX N/A
- EPS
- CHEB N/A
- MGX N/A
- Revenue
- CHEB N/A
- MGX $55,080,000.00
- Revenue This Year
- CHEB N/A
- MGX $16.91
- Revenue Next Year
- CHEB N/A
- MGX N/A
- P/E Ratio
- CHEB N/A
- MGX N/A
- Revenue Growth
- CHEB N/A
- MGX 45.13
- 52 Week Low
- CHEB $9.97
- MGX $1.61
- 52 Week High
- CHEB $26.25
- MGX $12.74
- Technical
- Relative Strength Index (RSI)
- CHEB N/A
- MGX 41.75
- Support Level
- CHEB N/A
- MGX $2.96
- Resistance Level
- CHEB N/A
- MGX $4.06
- Average True Range (ATR)
- CHEB 0.00
- MGX 0.37
- MACD
- CHEB 0.00
- MGX -0.16
- Stochastic Oscillator
- CHEB 0.00
- MGX 5.20
About CHEB CHENGHE ACQUISITION II CO
Chenghe Acquisition II Co is a blank check company.
About MGX METAGENOMI INC
Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. Genetic diseases are caused by a diverse set of mutations that have been largely inaccessible by genome engineering approaches to date. The genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems (including prime editing systems and clustered regularly interspaced short palindromic repeat (CRISPR)-associated transposases (CASTs).